URBN
76
-6
APH
77
2
VNO
54
-5
DOV
42
-3
XYL
64
2
TEL
72
-2
CNX
44
6
GS
70
-2
GILD
63
-2
AXP
67
-3
ICE
69
2
PGR
62
5
CLX
48
3
SWK
42
-3
PPL
67
3
GM
71
6
IFF
48
3
CL
56
2
CA
18
6
PFG
43
-2
URBN
76
-6
APH
77
2
VNO
54
-5
DOV
42
-3
XYL
64
2
TEL
72
-2
CNX
44
6
GS
70
-2
GILD
63
-2
AXP
67
-3
ICE
69
2
PGR
62
5
CLX
48
3
SWK
42
-3
PPL
67
3
GM
71
6
IFF
48
3
CL
56
2
CA
18
6
PFG
43
-2
Financhill
Back

Maze Therapeutics Stock Price Chart

Big exits started like this. So did Mode

Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/elite
Sell
17

MAZE
Maze Therapeutics

Last Price:
$12.01
Seasonality Move:
--

7 Day Trial

ALL ACCESS PASS

$ 7

From 50,000 investors to Nasdaq? Mode's next move...

Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/elite
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MAZE is experiencing selling pressure, which indicates risk of future bearish movement.

Maze Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 10.74 Sell
20-day SMA: 10.13 Sell
50-day SMA: 9.74 Buy
200-day SMA: 0 Buy
8-day EMA: 10.69 Sell
20-day EMA: 10.22 Sell
50-day EMA: 7.79 Buy
200-day EMA: 3.13 Buy

Maze Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.38 Buy
Relative Strength Index (14 RSI): 49.03 Sell
Chaikin Money Flow: -116988 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.99 - 10.83) Buy
Bollinger Bands (100): ( - ) Buy

Maze Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Maze Therapeutics Stock

Is Maze Therapeutics Stock a Buy?

  • Maze Therapeutics share price is 9.97 while MAZE 8-day simple moving average is 10.74, which is a Sell signal.
  • The stock price of MAZE is 9.97 while Maze Therapeutics 20-day SMA is 10.13, which makes it a Sell.
  • Maze Therapeutics 50-day simple moving average is 9.74 while MAZE share price is 9.97, making it a Buy technically.
  • MAZE stock price is 9.97 and Maze Therapeutics 200-day simple moving average is 0.00, creating a Buy signal.

MAZE Technical Analysis vs Fundamental Analysis

Sell
17
Maze Therapeutics (MAZE) is a Sell

Is Maze Therapeutics a Buy or a Sell?

  • Maze Therapeutics stock is rated a Sell
    The current Maze Therapeutics [MAZE] share price is $9.97. The Score for MAZE is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.

Maze Therapeutics Stock Info

Market Cap:
427M
Price in USD:
9.97
Share Volume:
147.2K

Maze Therapeutics 52-Week Range

52-Week High:
17.00
52-Week Low:
6.71
Sell
17
Maze Therapeutics (MAZE) is a Sell

Maze Therapeutics Share Price Forecast

Is Maze Therapeutics Stock a Buy?

  • Maze Therapeutics share price is 9.97 while MAZE 8-day exponential moving average is 10.69, which is a Sell signal.
  • The stock price of MAZE is 9.97 while Maze Therapeutics 20-day EMA is 10.22, which makes it a Sell.
  • Maze Therapeutics 50-day exponential moving average is 7.79 while MAZE share price is 9.97, making it a Buy technically.
  • MAZE stock price is 9.97 and Maze Therapeutics 200-day simple moving average is 3.13, creating a Buy signal.

Fundamental Analysis of Maze Therapeutics

Is Maze Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.07 per share, an increase this year of $16.03 per share, and an increase next year of $0.67 per share.

Technical Analysis of Maze Therapeutics

Should I short Maze Therapeutics stock?

* Maze Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.